ASLAN Pharmaceuticals today announced that it has raised US$23 million in a pre-IPO financing round.
The new financing round has attracted support from both new and existing investors. New investors include leading Taiwan institutional funds, TopTaiwan, KGI VC and Ta Ya Ventures, as well as several international institutional funds, Milestone Capital, Daiwa Taiwan-Japan Biotech Fund and China Galaxy.
For more details, please refer to English or Chinese press release.